The CAS registry number for GHK-Cu (Copper Peptide) is 49557-75-7
Synergistic Dual-Receptor Activation Combined stimulation of GHRH and GHS-R1a receptors leads to amplified and sustained GH release, mimicking natural physiologic pulsatility more effectively than monotherapy
Originally developed for diabetes management, these GLP-1 receptor agonists have shown impressive results in clinical trials helping many patients lose 1521% of their body weight under controlled study conditions
Glutathione l cht chng oxy ha mnh c tc dng ngn nga gc t do gy nm, sm, tn nhang, lo ha v cc bnh v da
Also, the casein kinase 2 (CK2), a highly conserved serine/threonine protein kinase with dual functionality in cellular growth/proliferation and suppression of apoptosis [205], can phosphorylate NRF2 in more than ten sites within Neh4 and Neh5 domains [206], leading to NRF2 translocation to the nucleus and its activation [207]
How GHK-Cu Works on Fine Lines and Wrinkles GHK Cu has multiple mechanisms that contribute to its effectiveness in reducing fine lines and wrinkles